Opendata, web and dolomites
H2020 projects about "aml"
The page lists 32 projects related to the topic "aml".
| # | |||
|---|---|---|---|
| 1 | ApoptoMDS | Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe? | 2015 |
| 2 | ONCOMECHAML | Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia | 2015 |
| 3 | PNANOMED | Personalized Nanomedicines for Leukemia Patients | 2015 |
| 4 | COMAL | COMAL:COhesin Mutations in Acute Leukemia: from modeling and mechanisms to novel therapeutics | 2015 |
| 5 | AML-VACCiN | Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia | 2016 |
| 6 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
| 7 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 8 | HOXA9 degradome | Deciphering the machinery involved in stability of the transcription factor HOXA9. | 2016 |
| 9 | MAMLE | Understanding the mechanisms of human acute myeloid leukaemia (AML) evolution | 2017 |
| 10 | LEUKEMIC-TEs | Unveiling the signature of transposable elements-derived transcripts – the transposcriptome – as a biomarker in human acute myeloid leukemia | 2017 |
| 11 | DNAmethAML | Investigation of aberrant DNA methylation in malignant haematopoiesis | 2018 |
| 12 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
| 13 | ContraNPM1AML | Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia | 2017 |
| 14 | iAML-lncTARGET | Targeting the transcriptional landscape in infant AML | 2017 |
| 15 | TREAT-NPM1-AML | Improving therapy of NPM1-mutated AML | 2017 |
| 16 | AltCheM | In vivo functional screens to decipher mechanisms of stochastically- and mutationally-induced chemoresistance in Acute Myeloid Leukemia | 2018 |
| 17 | ITHACA | Immuno-targeting of human AML quiescent cells by a novel phage display approach. | 2018 |
| 18 | TET2rec | Mechanisms of TET2 DNA demethylase recruitment to specific genomic regions | 2018 |
| 19 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 20 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 21 | TFs-HSCs | The identification of the Combinatorial Transcription Factor network exerting different roles in Hematopoietic Stem Cells. | 2019 |
| 22 | ProMeta | Non-histone protein acetylation targets of KAT2A in AML | 2018 |
| 23 | SeroStrat | The first blood test for the early detection and prognosis of Acute Myeloid Leukaemia | 2018 |
| 24 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 25 | ONCOSMART | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2018 |
| 26 | VerifiedID | The online platform for Identity Verification that gives back personal data ownership to the citizens | 2018 |
| 27 | LOQR | Digital Identity Management Platform: Verifying, Authenticating and Managing the end-to-end Digital Identity Lifecycle | 2019 |
| 28 | SyLeNCe | Synapses between Leukaemia and its Neighbouring Cells | 2020 |
| 29 | PMLingAML | Using PML nuclear body biology to identify potential AML treatment targets | 2020 |
| 30 | Mitobetes | The role of Von Willebrand Domain-containing Protein 8 in mitochondrial physiology | 2020 |
| 31 | RECOBIN-PROTACs | Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy | 2020 |
| 32 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |